Liquidia - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsLiquidia

Liquidia(LQDA)

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

*Currency in USD

Company Revenue

Quarterly

Quarterly

Annual

Annual

Projections

*Quarterly sales USD (in millions)

Plot placeholder

Mock data
Subscribe for the real data

Revenue by Drug

Marketed Drugs

No data

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

,

pulmonary hypertension

Hyaluronate sodium

,

,

,

,

herpes zoster ophthalmicus

,

dry eye syndromes

,

meibomian gland dysfunction

,

,

keratoconjunctivitis

,

,

adenoviridae infections

,

,

,

retinal vein occlusion

,

macular degeneration

,

diabetic retinopathy

,

choroidal neovascularization

,

pathologic neovascularization

,

keratoconjunctivitis sicca

,

pulmonary arterial hypertension

,

familial primary pulmonary hypertension

Polyglycolic acid

renal cell carcinoma

,

digestive system neoplasms

,

gastrointestinal stromal tumors

,

neoplasm metastasis

,

colonic neoplasms

,

rectal neoplasms

,

ovarian neoplasms

,

,

colorectal neoplasms

,

,

pancreatic neoplasms

,

stomach neoplasms

,

,

,

hereditary autoinflammatory diseases

,

,

familial mediterranean fever

,

,

,

falciparum malaria

,

breast neoplasms

,

ebola hemorrhagic fever

,

,

klebsiella infections

,

pulmonary arterial hypertension

,

cardiovascular diseases

,

,

pulmonary hypertension

multiple sclerosis

,

relapsing-remitting multiple sclerosis

erectile dysfunction

,

erectile dysfunction

,

multiple sclerosis

,

relapsing-remitting multiple sclerosis

multiple sclerosis

,

relapsing-remitting multiple sclerosis

temporomandibular joint disorders

,

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use